NASDAQ | ETF
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio ofU. S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than 250 million.
The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index.
Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 3.43% |
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.27% |
| GLUE | Monte Rosa Therapeutics Inc | Healthcare | Biotechnology | 2.17% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 2.01% |
| JANX | Janux Therapeutics Inc | Healthcare | Biotechnology | 1.90% |
| XNCR | Xencor Inc | Healthcare | Biotechnology | 1.88% |
| RPTX | Repare Therapeutics Inc | Healthcare | Biotechnology | 1.85% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.83% |
| REPL | Replimune Group Inc | Healthcare | Biotechnology | 1.78% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.78% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 1.78% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.76% |
| ELVN | Enliven Therapeutics Inc. | Healthcare | Biotechnology | 1.73% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 1.71% |
| ZA8 | ZYMEWORKS DL-00001 | Healthcare | Biotechnology | 1.70% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.69% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 1.69% |
| MRSN | Mersana Therapeutics Inc | Healthcare | Biotechnology | 1.64% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.61% |
| IPHA | Innate Pharma | Healthcare | Biotechnology | 1.58% |